Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

33%

Ph phase_3

33%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 3Large-scale testing

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Detailed Status

Completed2

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (33.3%)

Phase 31 (33.3%)

N/A1 (33.3%)

Trials by Status

completed267%

withdrawn133%

Recent Activity

0 active trials

Showing 3 of 3

withdrawnnot_applicable

Anodal Transcranial Direct Current Stimulation of the Visual Cortex Versus Sham Stimulation in the Episodic Migraine

NCT02122757

completedphase_3

Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial

NCT02122237

completedphase_1

Neurophysiological Study of tDCS Effects in Healthy Volunteers

NCT02125422

Clinical Trials (3)

Showing 3 of 3 trials

NCT02122757Not Applicable

Anodal Transcranial Direct Current Stimulation of the Visual Cortex Versus Sham Stimulation in the Episodic Migraine

Withdrawn

NCT02122237Phase 3

Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial

Completed

NCT02125422Phase 1

Neurophysiological Study of tDCS Effects in Healthy Volunteers

Completed

All 3 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 3